18β-Glycyrrhetinic acid suppresses allergic airway inflammation through NF-κB and Nrf2/HO-1 signaling pathways in asthma mice | Scientific Reports
Glycyrrhizin - Wikipedia
18β‐Glycyrrhetinic acid: its core biological properties and dermatological applications - Kowalska - 2019 - International Journal of Cosmetic Science - Wiley Online Library
Glycyrrhetinic Acid - Leader In Anti-Aging & Hormone Replacement For Men And Women In USA
Frontiers | Metabolic Engineering for Glycyrrhetinic Acid Production in Saccharomyces cerevisiae
Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy | Molecular Pharmaceutics
18-b-Glycyrrhetinic acid
β-Glycyrrhetinic acid | CAS# 471-53-4 | 9586 | BioVision, Inc.
18β-Glycyrrhetinic acid-d3 | Stable Isotope | MedChemExpress
Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
471-53-4・グリチルレチン酸・Glycyrrhetinic Acid・072-02181【詳細情報】｜【分析】｜試薬-富士フイルム和光純薬
18b-Glycyrrhetinic acid 97 471-53-4
Glycyrrhetinic acid | C30H46O4 - PubChem
18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration
Glycyrrhetinic acid – Glabridin
Synthesis, anti-microbial and anti-inflammatory activities of 18β-glycyrrhetinic acid derivatives - ScienceDirect
18β-Glycyrrhetinic Acid (Arthrodont, Biosone, Enoxolone, α-Glycyrrhetinic Acid, GM 1658, NSC 35347, PO 12, STX 352, CAS Number: 471-53-4) | Cayman Chemical
Pharmaceutics | Free Full-Text | Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer
Glycyrrhetinic Acid 98% | CAS 471-53-4 | Buy Today!
Glycyrrhetinic acid | MarkHerb
File:Glycyrrhetinic acid.svg - Wikimedia Commons
Chemical structure of glycyrrhetinic acid. | Download Scientific Diagram
18-beta-Glycyrrhetinic acid 0043 S, CAS 471-53-4 - Oleanane - Extrasynthese
β-GLYCYRRHETINIC ACID | Products | Alps Pharmaceutical Ind. Co.,Ltd.
Molecules | Free Full-Text | Synthesis, Characterization, In Vitro Anticancer Potentiality, and Antimicrobial Activities of Novel Peptide– Glycyrrhetinic-Acid-Based Derivatives
